Twin Studies in Inflammatory Bowel Disease- A Review

[1]  K. Bodger,et al.  Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients , 2002, Gut.

[2]  M. D’Amato,et al.  CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[3]  S. Isaacs,et al.  PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers , 1992, Digestive Diseases and Sciences.

[4]  J. Rhodes,et al.  Altered lectin binding by colonic epithelial glycoconjugates in ulcerative colitis and Crohn's disease , 1988, Digestive Diseases and Sciences.

[5]  T. Ahmad,et al.  Clinical relevance of advances in genetics and pharmacogenetics of IBD. , 2004, Gastroenterology.

[6]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[7]  R. Caprilli,et al.  CARD15 and Toll-like receptors: the link with Crohn’s disease , 2003 .

[8]  B. Sartor,et al.  Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when , 2003, Current opinion in gastroenterology.

[9]  E. Lindberg,et al.  Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.

[10]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[11]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[12]  P. Rutgeerts,et al.  Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families , 2001, Inflammatory bowel diseases.

[13]  M. Scheurlen,et al.  Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study , 2001, Scandinavian journal of gastroenterology.

[14]  S. Targan,et al.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.

[15]  D. Jewell,et al.  A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.

[16]  S. Targan,et al.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease , 2000, Gut.

[17]  T. Sørensen,et al.  Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. , 2000, Scandinavian journal of gastroenterology.

[18]  E. Lindberg,et al.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn’s disease: an inherited defect in mucosal defence? , 1999, Gut.

[19]  O. Goulet,et al.  Anti-Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease , 1998, American Journal of Gastroenterology.

[20]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[21]  R. Pounder,et al.  Concordance rates of twins and siblings in inflammatory bowel disease (IBD) , 1998 .

[22]  R. Pounder,et al.  Genetics versus environment in inflammatory bowel disease: results of a British twin study , 1996, BMJ.

[23]  E. Lindberg,et al.  Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. , 1995, Scandinavian journal of gastroenterology.

[24]  E. Lindberg,et al.  P-ANCA in monozygotic twins with inflammatory bowel disease. , 1995, Gut.

[25]  A. Macpherson,et al.  Intestinal permeability: an overview. , 1995, Gastroenterology.

[26]  C. Florén,et al.  Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden. A 25-year incidence study. , 1995, Scandinavian journal of gastroenterology.

[27]  T. Halstensen,et al.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. , 1993, Gut.

[28]  E. Lindberg,et al.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. , 1992, Gut.

[29]  D. Hollander,et al.  The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. , 1992, Scandinavian journal of gastroenterology.

[30]  S. Targan,et al.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. , 1992, Gastroenterology.

[31]  E. Lindberg,et al.  Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. , 1992, Gut.

[32]  S. Travis,et al.  Intestinal permeability: functional assessment and significance. , 1992, Clinical science.

[33]  A. Levi,et al.  Intestinal permeability in patients with Crohn's disease and their first degree relatives. , 1992, Gut.

[34]  E. Lindberg,et al.  Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. , 1991, Gastroenterology.

[35]  T. Sørensen,et al.  Familial occurrence of inflammatory bowel disease. , 1991, The New England journal of medicine.

[36]  A. Sonnenberg,et al.  Geographic variation of inflammatory bowel disease within the United States. , 1991, Gastroenterology.

[37]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[38]  E. Lindberg,et al.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. , 1988, Gut.

[39]  J. Rotter,et al.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.

[40]  K. Isselbacher,et al.  Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. , 1984, Gastroenterology.

[41]  K. Isselbacher,et al.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. , 1983, The Journal of clinical investigation.

[42]  A. Price.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'. , 1978, Journal of clinical pathology.